![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DCTN2 |
Gene summary for DCTN2 |
![]() |
Gene information | Species | Human | Gene symbol | DCTN2 | Gene ID | 10540 |
Gene name | dynactin subunit 2 | |
Gene Alias | DCTN50 | |
Cytomap | 12q13.3 | |
Gene Type | protein-coding | GO ID | GO:0000070 | UniProtAcc | Q13561 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10540 | DCTN2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.14e-03 | 4.20e-01 | -0.0811 |
10540 | DCTN2 | HTA11_347_2000001011 | Human | Colorectum | AD | 5.91e-15 | 5.49e-01 | -0.1954 |
10540 | DCTN2 | HTA11_83_2000001011 | Human | Colorectum | SER | 6.18e-03 | 3.74e-01 | -0.1526 |
10540 | DCTN2 | HTA11_696_2000001011 | Human | Colorectum | AD | 8.80e-10 | 4.23e-01 | -0.1464 |
10540 | DCTN2 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.27e-09 | 3.74e-01 | -0.1001 |
10540 | DCTN2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.12e-09 | 5.03e-01 | -0.059 |
10540 | DCTN2 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.02e-09 | 4.56e-01 | 0.096 |
10540 | DCTN2 | HTA11_10623_2000001011 | Human | Colorectum | AD | 1.09e-02 | 4.71e-01 | -0.0177 |
10540 | DCTN2 | HTA11_6801_2000001011 | Human | Colorectum | SER | 3.52e-02 | 6.23e-01 | 0.0171 |
10540 | DCTN2 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.56e-08 | 3.19e-01 | 0.0674 |
10540 | DCTN2 | HTA11_7469_2000001011 | Human | Colorectum | AD | 4.11e-05 | 6.39e-01 | -0.0124 |
10540 | DCTN2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.63e-02 | 2.43e-01 | 0.294 |
10540 | DCTN2 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.17e-17 | 5.46e-01 | 0.3859 |
10540 | DCTN2 | A002-C-205 | Human | Colorectum | FAP | 1.32e-02 | -1.70e-01 | -0.1236 |
10540 | DCTN2 | A002-C-116 | Human | Colorectum | FAP | 4.84e-04 | -1.53e-01 | -0.0452 |
10540 | DCTN2 | F034 | Human | Colorectum | FAP | 3.12e-02 | -1.45e-01 | -0.0665 |
10540 | DCTN2 | LZE4T | Human | Esophagus | ESCC | 3.18e-15 | 5.78e-01 | 0.0811 |
10540 | DCTN2 | LZE5T | Human | Esophagus | ESCC | 2.21e-03 | 1.76e-01 | 0.0514 |
10540 | DCTN2 | LZE7T | Human | Esophagus | ESCC | 2.80e-08 | 8.01e-01 | 0.0667 |
10540 | DCTN2 | LZE8T | Human | Esophagus | ESCC | 2.66e-16 | 5.85e-01 | 0.067 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051656 | Colorectum | AD | establishment of organelle localization | 131/3918 | 390/18723 | 3.00e-09 | 2.06e-07 | 131 |
GO:0051650 | Colorectum | AD | establishment of vesicle localization | 57/3918 | 161/18723 | 1.47e-05 | 3.15e-04 | 57 |
GO:0051648 | Colorectum | AD | vesicle localization | 59/3918 | 177/18723 | 7.83e-05 | 1.25e-03 | 59 |
GO:0071539 | Colorectum | AD | protein localization to centrosome | 16/3918 | 33/18723 | 3.86e-04 | 4.41e-03 | 16 |
GO:0007051 | Colorectum | AD | spindle organization | 58/3918 | 184/18723 | 4.71e-04 | 5.20e-03 | 58 |
GO:1902850 | Colorectum | AD | microtubule cytoskeleton organization involved in mitosis | 48/3918 | 147/18723 | 5.87e-04 | 6.21e-03 | 48 |
GO:1905508 | Colorectum | AD | protein localization to microtubule organizing center | 16/3918 | 35/18723 | 8.76e-04 | 8.51e-03 | 16 |
GO:0007052 | Colorectum | AD | mitotic spindle organization | 40/3918 | 120/18723 | 1.03e-03 | 9.61e-03 | 40 |
GO:0140014 | Colorectum | AD | mitotic nuclear division | 78/3918 | 287/18723 | 6.48e-03 | 4.05e-02 | 78 |
GO:00516561 | Colorectum | SER | establishment of organelle localization | 100/2897 | 390/18723 | 1.11e-07 | 6.79e-06 | 100 |
GO:00516501 | Colorectum | SER | establishment of vesicle localization | 42/2897 | 161/18723 | 3.38e-04 | 5.35e-03 | 42 |
GO:00516481 | Colorectum | SER | vesicle localization | 43/2897 | 177/18723 | 1.41e-03 | 1.53e-02 | 43 |
GO:00516562 | Colorectum | MSS | establishment of organelle localization | 115/3467 | 390/18723 | 7.30e-08 | 3.67e-06 | 115 |
GO:00516502 | Colorectum | MSS | establishment of vesicle localization | 51/3467 | 161/18723 | 3.92e-05 | 7.45e-04 | 51 |
GO:00715391 | Colorectum | MSS | protein localization to centrosome | 16/3467 | 33/18723 | 8.66e-05 | 1.40e-03 | 16 |
GO:00516482 | Colorectum | MSS | vesicle localization | 53/3467 | 177/18723 | 1.47e-04 | 2.16e-03 | 53 |
GO:19055081 | Colorectum | MSS | protein localization to microtubule organizing center | 16/3467 | 35/18723 | 2.07e-04 | 2.89e-03 | 16 |
GO:00070511 | Colorectum | MSS | spindle organization | 53/3467 | 184/18723 | 4.23e-04 | 5.19e-03 | 53 |
GO:19028501 | Colorectum | MSS | microtubule cytoskeleton organization involved in mitosis | 44/3467 | 147/18723 | 5.17e-04 | 5.98e-03 | 44 |
GO:00070521 | Colorectum | MSS | mitotic spindle organization | 36/3467 | 120/18723 | 1.52e-03 | 1.39e-02 | 36 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05016 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa05014 | Colorectum | AD | Amyotrophic lateral sclerosis | 164/2092 | 364/8465 | 4.28e-18 | 1.27e-16 | 8.09e-17 | 164 |
hsa05022 | Colorectum | AD | Pathways of neurodegeneration - multiple diseases | 201/2092 | 476/8465 | 4.54e-18 | 1.27e-16 | 8.09e-17 | 201 |
hsa05132 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
hsa04962 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
hsa050161 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa050141 | Colorectum | AD | Amyotrophic lateral sclerosis | 164/2092 | 364/8465 | 4.28e-18 | 1.27e-16 | 8.09e-17 | 164 |
hsa050221 | Colorectum | AD | Pathways of neurodegeneration - multiple diseases | 201/2092 | 476/8465 | 4.54e-18 | 1.27e-16 | 8.09e-17 | 201 |
hsa051321 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
hsa049621 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
hsa050162 | Colorectum | SER | Huntington disease | 127/1580 | 306/8465 | 3.29e-21 | 1.37e-19 | 9.92e-20 | 127 |
hsa050222 | Colorectum | SER | Pathways of neurodegeneration - multiple diseases | 168/1580 | 476/8465 | 6.23e-19 | 2.07e-17 | 1.50e-17 | 168 |
hsa050142 | Colorectum | SER | Amyotrophic lateral sclerosis | 138/1580 | 364/8465 | 9.89e-19 | 2.99e-17 | 2.17e-17 | 138 |
hsa051322 | Colorectum | SER | Salmonella infection | 77/1580 | 249/8465 | 1.56e-06 | 2.35e-05 | 1.71e-05 | 77 |
hsa050163 | Colorectum | SER | Huntington disease | 127/1580 | 306/8465 | 3.29e-21 | 1.37e-19 | 9.92e-20 | 127 |
hsa050223 | Colorectum | SER | Pathways of neurodegeneration - multiple diseases | 168/1580 | 476/8465 | 6.23e-19 | 2.07e-17 | 1.50e-17 | 168 |
hsa050143 | Colorectum | SER | Amyotrophic lateral sclerosis | 138/1580 | 364/8465 | 9.89e-19 | 2.99e-17 | 2.17e-17 | 138 |
hsa051323 | Colorectum | SER | Salmonella infection | 77/1580 | 249/8465 | 1.56e-06 | 2.35e-05 | 1.71e-05 | 77 |
hsa050164 | Colorectum | MSS | Huntington disease | 141/1875 | 306/8465 | 2.90e-21 | 1.62e-19 | 9.92e-20 | 141 |
hsa050224 | Colorectum | MSS | Pathways of neurodegeneration - multiple diseases | 192/1875 | 476/8465 | 2.79e-20 | 1.04e-18 | 6.36e-19 | 192 |
Page: 1 2 3 4 5 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DCTN2 | SNV | Missense_Mutation | novel | c.669N>A | p.Phe223Leu | p.F223L | Q13561 | protein_coding | tolerated(0.24) | benign(0.245) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DCTN2 | SNV | Missense_Mutation | c.274N>A | p.Glu92Lys | p.E92K | Q13561 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-D8-A1JJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine | SD | |
DCTN2 | SNV | Missense_Mutation | c.1139N>G | p.Gln380Arg | p.Q380R | Q13561 | protein_coding | deleterious(0) | possibly_damaging(0.791) | TCGA-D8-A1XK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide | SD | |
DCTN2 | SNV | Missense_Mutation | novel | c.487N>A | p.Leu163Met | p.L163M | Q13561 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
DCTN2 | SNV | Missense_Mutation | rs374804015 | c.649N>T | p.Arg217Trp | p.R217W | Q13561 | protein_coding | deleterious(0) | probably_damaging(0.923) | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
DCTN2 | SNV | Missense_Mutation | rs141248212 | c.823N>A | p.Ala275Thr | p.A275T | Q13561 | protein_coding | tolerated(0.17) | benign(0.001) | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DCTN2 | SNV | Missense_Mutation | novel | c.139N>C | p.Ser47Arg | p.S47R | Q13561 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DCTN2 | SNV | Missense_Mutation | c.680C>T | p.Ala227Val | p.A227V | Q13561 | protein_coding | tolerated(0.08) | possibly_damaging(0.79) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
DCTN2 | SNV | Missense_Mutation | c.467C>T | p.Ala156Val | p.A156V | Q13561 | protein_coding | deleterious(0.04) | benign(0.145) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
DCTN2 | SNV | Missense_Mutation | novel | c.460N>A | p.Leu154Met | p.L154M | Q13561 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-T9-A92H-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |